Beta blocker may help reduce heart attack damage, study finds

10/8/2013 | DailyRx.com

Heart attack patients who were treated with the low-cost beta blocker metoprolol on their way to the hospital had 20% less heart tissue damage than those who received a placebo, according to a study in the journal Circulation. Patients with less heart tissue damage are less likely to require an implantable defibrillator and other expensive treatments or need long hospitalization, researchers said.

View Full Article in:

DailyRx.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA